Tackling antimicrobial resistance, one genome at a time - Illumina
#antimicrobial resistance#Tackling antimicrobial#Illumina Tackling#time Illumina#resistance
Life Science News
Latest updates from the biotech and pharma world
Agilent to Participate in Citi’s 2025 Global Healthcare Conference - Business Wire
#Global Healthcare#Healthcare Conference#Business Wire#Conference Business#Wire Agilent
Thermo Fisher Scientific Opens East Coast Collaboration Center at BioLabs - citybiz
#Fisher Scientific#Scientific Opens#Opens East#East Coast#Coast Collaboration
Agilent Wants Justices To Eye Invalidation Of CRISPR Patents - Law360
#CRISPR Patents#Eye Invalidation#Patents#Agilent#Justices
Roche Had A Positive Cancer Study — And Its Rival Flew 130% - Investor's Business Daily
#Cancer Study#Rival Flew#Investor Business#Positive Cancer#Business Daily
10x Genomics at Wolfe Research Healthcare: Navigating Challenges and Opportunities - Investing.com
#Research Healthcare#Navigating Challenges#Wolfe Research#Opportunities Investing.com#Genomics
Thermo Fisher targets early-stage CGT bottlenecks with new Philadelphia hub - R&D World
#Thermo Fisher#Fisher targets#early-stage CGT#CGT bottlenecks#Philadelphia hub
Roche pill notches win in early breast cancer - BioPharma Dive
#Roche pill#BioPharma Dive#pill notches#notches win#early breast
Raiffeisen Bank International AG Raises Holdings in Agilent Technologies, Inc. $A - MarketBeat
#Agilent Technologies#Bank International#Raises Holdings#Raiffeisen Bank#Technologies
Lab-grown models of human brains are advancing rapidly. Can ethics keep pace?
#Lab-grown models#advancing rapidly#human brains#Lab-grown#rapidly
CRISPR/Cas9 Knock-In Tagging: Simplifying the Study of Endogenous Biology
#Biology Understanding#Knock-In Tagging#Endogenous Biology#native environment#fundamental goal
Roche's oral SERD notches second pivotal breast cancer win - FirstWord Pharma
#oral SERD#SERD notches#Roche oral#FirstWord Pharma#pivotal breast
OLMA Stock Doubles After Roche Cancer Drug Trial Yields Positive Results - Stocktwits
#Stock Doubles#Roche Cancer#Cancer Drug#Drug Trial#Trial Yields
Roche's oral SERD goes 2 for 2, hitting goal in phase 3 adjuvant breast cancer trial - Fierce Biotech
#Fierce Biotech#oral SERD#hitting goal#adjuvant breast#Roche oral
10x Genomics (Nasdaq: TXG) Xenium Powers ASTRA Atlas of 2,000 Asia-Pacific Tumor Samples - Stock Titan
#Xenium Powers#Stock Titan#Powers ASTRA#ASTRA Atlas#Asia-Pacific Tumor
New ASTRA Consortium Unites Asia-Pacific Scientists to Build Pan-Cancer Spatial Atlas Powered by 10x Genomics' Xenium - PR Newswire
#Genomics' Xenium#ASTRA Consortium#Consortium Unites#Spatial Atlas#Atlas Powered
Freenome Announces Exclusive Agreement with Roche to Expand Technology Collaboration and Develop and Commercialize Cancer Screening Tests Outside the U.S. - PR Newswire
#Announces Exclusive#Exclusive Agreement#Expand Technology#Technology Collaboration#Commercialize Cancer
Roche touts early giredestrant success | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
#Clinical Trials#Oncology Pipeline#giredestrant success#Roche touts#touts early
Monster Beverage, UnitedHealth, Thermo Fisher Scientific And More: CNBC's 'Final Trades' - Benzinga
#Thermo Fisher#Final Trades'#Fisher Scientific#Monster Beverage#Trades' Benzinga
Roche boosts Olema as breast cancer therapy succeeds in late-stage trial - Seeking Alpha
#Seeking Alpha#boosts Olema#Roche boosts#breast cancer#cancer therapy